Abstract
Stroke is a complex neurological disorder, and the risk factors and genetic biomarkers associated with its development are not completely understood. This study aims to identify putative causal traits and their biomarkers that influence the risk of stroke. We leveraged genome-wide association studies (GWAS) datasets to understand potential causal genetic relationships between stroke and 1,504 complex traits via the latent causal variable (LCV) and Generalised Mendelian randomisation (GSMR) methods. Our results suggest 14 traits showing potential causal genetic effects with stroke risk (|GCP|> 0.60; FDR < 0.05). These traits include cardiovascular, metabolic, and blood clot-related traits. Using mBAT-combo, we identified genes associated with these putatively causal traits and stroke, suggesting shared genetic architectures. Colocalisation analysis showed that several of those overlapping genes were colocalised between stroke and risk traits. Functional enrichment analyses of the overlapping genes highlight the role of coagulation and complement systems, specifically prothrombin and platelet activation, as well as complement and coagulation cascades. This study suggests putative causal genetic architecture and biological pathways shared between stroke and its causal traits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study does not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos